A national class action in Canada has been commenced against Medtronic (NYSE:MDT) over its MiniMed 630G and 670G insulin pumps.
Rochon Genova and Cardill Law commenced the proposed class action suit against Medtronic, Medtronic MiniMed and Medtronic of Canada over the insulin pumps approved for use in the country in 2016 and 2018. The pumps have become subject to some issues, with the most recent coming in the form of an expansion of an FDA Class I recall that resulted in 463,464 devices being recalled.
Get the full story at our sister site, Drug Delivery Business News.